Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An award-winning Oxford-based international project to tackle antibiotic resistance has achieved its one millionth classification.

BashTheBug is an initiative based in the University of Oxford’s Modernising Medical Microbiology Group (Nuffield Department of Clinical Medicine) at the John Radcliffe Hospital and supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC).

Find out more (NIHR OxBRC website)

Similar stories

Shipment of R21 malaria vaccine to Central African Republic marks latest milestone for child survival

Last month, UNICEF delivered over 43,200 doses of the R21/Matrix-M malaria vaccine developed through collaboration between Oxford University’s Jenner Institute and Serum Institute of India leveraging by Novavax’s saponin-based adjuvant technology, by air to Bangui, Central African Republic, with further shipment of about 163,800 doses to follow, which is allocated for children in the CAR currently.